← Browse by Condition
Medical Condition

neoplasm recurrence local

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06532539 Phase 2
Recruiting

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Enrollment
30 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
View Trial →